MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/archdischild-2018-315060

Медицинская библиотека · Archives of disease in childhood · 2018

Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis.

Skrabl-Baumgartner Andrea, Seidel Gerald, Langner-Wegscheider Beate, Schlagenhauf Axel, Jahnel Jörg

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Assessing influence of anti-adalimumab (ADA) antibodies (AAA) on serum trough ADA levels and uveitis activity in long-term ADA treatment of juvenile idiopathic arthritis (JIA)-associated uveitis.

PATIENTS AND INTERVENTIONS: This prospective observational study included 20 patients from a single centre treated with ADA for active uveitis refractory to conventional disease-modifying antirheumatic drugs. AAA, serum ADA trough levels and uveitis activity were evaluated at regular intervals up to 6 years.

RESULTS

AAA were detected in nine patients (45%). Permanent AAA in seven were associated with undetectable ADA trough levels and loss of response (LOR). Transient AAA were detected in four with measurable ADA trough levels and response of uveitis to treatment, followed in two by permanent AAA associated with LOR. Use of concomitant immunosuppression was significantly higher in patients without AAA (p<0.05).

CONCLUSIONS

AAA-associated LOR frequently occurs in long-term treatment with ADA for JIA-associated uveitis. Concomitant immunosuppressive therapy significantly reduces the risk of LOR due to AAA.

Для цитирования: Skrabl-Baumgartner Andrea, Seidel Gerald, Langner-Wegscheider Beate, Schlagenhauf Axel, Jahnel Jörg. Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis.. Archives of disease in childhood. 2018. DOI: 10.1136/archdischild-2018-315060.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.